Alkem Laboratories IPO Details

Issue Open Dec 8, 2015
Issue Close Dec 10, 2015
IPO Price ₹1050
Face Value ₹2
IPO Size ₹1,349.61 Cr
Listing At BSE, NSE
IPO Lot Size 14
  1. Clifford Chance

    Wed, 17 Feb 2021 16:00:00 GMT

    JP Morgan India and Edelweiss Financial Services on the Rs 1,350 crore initial public offer (IPO) of Indian pharma global giant Alkem Laboratories. Alkem was advised by Khaitan & Co. CAM Mumbai ...

  2. Alkem Laboratories Ltd.

    Thu, 18 Feb 2021 16:00:00 GMT

    Srinivas Singh has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeov ...

  3. Volumes soar at Alkem Laboratories Ltd counter

    Mon, 01 Mar 2021 01:39:00 GMT

    Alkem Laboratories Ltd recorded volume of 66600 shares by 10:48 IST on BSE, a 9.96 times surge over two-week average daily volume of 6688 shares. The stock gained 0.60% to Rs.2,735.00. Volumes ...

  4. Sensex rebounds 260 points to close at three-week high of 25,850

    Tue, 22 Dec 2015 22:13:00 GMT

    Alkem, India’s fifth-largest ... Dr Lal Pathlabs, which operates a chain of 172 laboratories across the country, raised Rs 632 crore through the IPO, which also closed on December 10.

  5. Twelve Seas Investment Company II Announces Pricing of Upsized $300,000,000 Initial Public Offering

    Thu, 25 Feb 2021 20:35:00 GMT

    Los Angeles, CA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company II (the “Company”) announced today that it priced its initial public offering of 30,000,000 units at $10.00 ...

  6. Medlife in advanced talks to buy 2 pharmacy retail chains; adopts omni channel route for growth

    Wed, 08 May 2019 07:04:00 GMT

    He is the son of Prabhat Narain Singh, one of the founders of Alkem Laboratories ... If we need further money, we would look at an IPO or a fund raise at a later date," Kumar said.

  7. Worldwide Anti-Viral Drug Therapy Industry to 2030 - Featuring Abbott Laboratories, AbbVie and Alkem Laboratories Among Others

    Wed, 10 Feb 2021 12:59:00 GMT

    DUBLIN, Feb. 10, 2021 /PRNewswire/ -- The "Anti-Viral Drug Therapy Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets ...

  8. Paytm founder Vijay Shekhar Sharma youngest Indian on Forbes list of billionaires

    Fri, 15 Jan 2021 08:19:00 GMT

    Singh founded the pharma firm Alkem Laboratories 45 years ago ... have more than doubled since its November 2016 IPO. For the year ended March 2017, Alkem reported a 20% rise in net earnings ...

  9. What changed for the market while you were sleeping? Top 10 things to know

    Thu, 04 Feb 2021 19:01:00 GMT

    Sebi slaps Rs 1.2 crore fine on 6 entities for IPO fund diversion ... Aditya Birla Capital, Alkem Laboratories, Ashoka Buildcon, Mrs Bectors Food Specialities, Cadila Healthcare, CG Power and ...

  10. Market rallies for 3rd day; Sensex closes above 50,000 mark, Nifty ends near 14,800

    Wed, 03 Feb 2021 03:53:00 GMT

    The stock was listed at Rs 612.15, at a premium of 18.18% to the initial public offer (IPO) price ... The index rose 4.98% in two sessions. Divis Laboratories, Torrent Pharmaceuticals, Cipla ...

Alkem Laboratories IPO Alerts

1. Listing Date for Alkem Laboratories Limited IPO Shares  Wednesday, December 23, 2015 12:00:00 AM

The Equity Shares of Alkem Laboratories Limited will list on the stock exchanges on Wednesday, December 23, 2015.

Detail of the Alkem Laboratories IPO Share Listing is as below:

› Listing Date: Wednesday, December 23, 2015
› BSE Script Code: 539523
› NSE Symbol: ALKEM
› Listing In: B Group of Securities
› ISIN: INE540L01014
› Issue Price: Rs. 1,050.00 Per Equity Share
› Face Value: Rs. 2.00 Per Equity Share

2. Alkem Laboratories IPO allotment status  Saturday, December 19, 2015 12:00:00 AM

Alkem Laboratories IPO allotment status is now available online.

Alkem Laboratories IPO subscribed 44.29 times. Public Issue of Alkem Laboratories was closed for subscription on Dec 10, 2015. Issue subscription detail:

Qualified Institutional Buyers (QIBs): 57.19 times
Non Institutional Investors (NII): 129.96 times
Retail Individual Investors (RIIs): 3.17 times
Employee: 0.67 times

Alkem Laboratories IPO Listing date will be available soon.

3. Alkem Laboratories Limited IPO - Close  Thursday, December 10, 2015 12:00:00 AM

Alkem Laboratories Limited IPO to open on Dec 8, 2015 and close for subscription on Dec 10, 2015. Company is raising Rs upto 1,349.61 Cr to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale of up to 12,853,442 Equity Shares. The equity shares of the company to be list at BSE and NSE.

4. Alkem Laboratories Limited IPO - Open  Tuesday, December 8, 2015 12:00:00 AM

Alkem Laboratories Limited is entering in the capital markets with an initial public offering, IPO of 12,853,442 Equity Shares of Rs 2 each aggregating upto Rs 1,349.61 Cr. The price band for the issue has been fixed at Rs 1020 at lower level and Rs 1050 at upper level.

Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

The issue opens on Dec 8, 2015 and closes for subscription on Dec 10, 2015. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Alkem Laboratories IPO News & Events FAQs

  1. 1. When Alkem Laboratories IPO expected date?

    The Alkem Laboratories IPO is proposed to open on Dec 8, 2015. The IPO application ends on Dec 10, 2015.

  2. 2. How to purchase Alkem Laboratories IPO?

    Retail investors can apply in the retail or non-institutional investor category from Dec 8, 2015 to Dec 10, 2015. The Alkem Laboratories IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When Alkem Laboratories IPO will come?

    The Alkem Laboratories IPO will open for subscription on Dec 8, 2015. The public issue will close on Dec 10, 2015.


   I Like It. | Report Abuse


Download Our Mobile App

Android App iOS App